Elbit Medical Technologies Ltd (EMTC-M.TA)
ILA 16.1
(6.62%)
ILA 16.1
(6.62%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -17.79 Million USD | -248.15% |
| 2022 | -5.11 Million USD | 67.07% |
| 2021 | -15.52 Million USD | -112.61% |
| 2020 | 123.04 Million USD | 679.86% |
| 2019 | -21.22 Million USD | -179.12% |
| 2018 | 26.82 Million USD | 349.45% |
| 2017 | -10.75 Million USD | 42.36% |
| 2016 | -18.65 Million USD | -20.16% |
| 2015 | -15.52 Million USD | -65.54% |
| 2014 | -9.37 Million USD | 20.21% |
| 2013 | -11.75 Million USD | -130.34% |
| 2012 | 38.74 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 218 Thousand USD | 0.0% |
| 2024 Q1 | 218 Thousand USD | 102.86% |
| 2023 Q4 | -7.63 Million USD | 0.0% |
| 2023 FY | -17.79 Million USD | -248.15% |
| 2023 Q1 | -1.26 Million USD | -145.63% |
| 2023 Q2 | -1.26 Million USD | 0.0% |
| 2023 Q3 | -7.63 Million USD | -503.32% |
| 2022 Q4 | -515 Thousand USD | 0.0% |
| 2022 FY | -5.11 Million USD | 67.07% |
| 2022 Q3 | -515 Thousand USD | 74.76% |
| 2022 Q2 | -2.04 Million USD | 0.0% |
| 2022 Q1 | -2.04 Million USD | 65.04% |
| 2021 Q1 | -2.21 Million USD | -128.37% |
| 2021 Q4 | -5.83 Million USD | 0.0% |
| 2021 Q2 | -1.63 Million USD | 26.51% |
| 2021 Q3 | -5.83 Million USD | -258.04% |
| 2021 FY | -15.52 Million USD | -112.61% |
| 2020 FY | 123.04 Million USD | 679.86% |
| 2020 Q1 | 118.51 Million USD | 6583.42% |
| 2020 Q4 | 7.81 Million USD | 361.3% |
| 2020 Q3 | -2.99 Million USD | -874.59% |
| 2020 Q2 | -307 Thousand USD | -100.26% |
| 2019 Q4 | -1.82 Million USD | 61.45% |
| 2019 Q1 | 3.05 Million USD | -87.67% |
| 2019 Q2 | -17.7 Million USD | -679.38% |
| 2019 Q3 | -4.74 Million USD | 73.22% |
| 2019 FY | -21.22 Million USD | -179.12% |
| 2018 FY | 26.82 Million USD | 349.45% |
| 2018 Q4 | 24.79 Million USD | 107891.3% |
| 2018 Q3 | -23 Thousand USD | -100.65% |
| 2018 Q2 | 3.55 Million USD | 336.89% |
| 2018 Q1 | -1.49 Million USD | 17.11% |
| 2017 Q3 | -1.8 Million USD | 49.31% |
| 2017 Q1 | -3.56 Million USD | 36.33% |
| 2017 Q2 | -3.56 Million USD | 0.0% |
| 2017 FY | -10.75 Million USD | 42.36% |
| 2017 Q4 | -1.8 Million USD | 0.0% |
| 2016 Q1 | -4.78 Million USD | -73.26% |
| 2016 Q3 | -4.03 Million USD | 4.54% |
| 2016 Q2 | -4.22 Million USD | 11.74% |
| 2016 Q4 | -5.6 Million USD | -38.86% |
| 2016 FY | -18.65 Million USD | -20.16% |
| 2015 Q3 | -2.88 Million USD | 43.79% |
| 2015 Q1 | -4.73 Million USD | -130.48% |
| 2015 Q4 | -2.76 Million USD | 4.29% |
| 2015 Q2 | -5.13 Million USD | -8.53% |
| 2015 FY | -15.52 Million USD | -65.54% |
| 2014 Q2 | -3.34 Million USD | 31.63% |
| 2014 Q4 | -2.05 Million USD | -460.35% |
| 2014 Q3 | 570 Thousand USD | 117.06% |
| 2014 Q1 | -4.88 Million USD | -121.83% |
| 2014 FY | -9.37 Million USD | 20.21% |
| 2013 Q2 | -2.71 Million USD | 27.33% |
| 2013 FY | -11.75 Million USD | -130.34% |
| 2013 Q4 | -2.2 Million USD | 28.77% |
| 2013 Q3 | -3.09 Million USD | -13.8% |
| 2013 Q1 | -3.74 Million USD | 0.0% |
| 2012 FY | 38.74 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|